Secretin

Links shared publicly online about this topic

Some Benefits for Autistic Children From Medications & ABA, None From Secretin

care2.com — “The results of three new studies about treatments for autistic children---one about an 'alternative medicine' treatment, one about medications, and one about educational-behavioral therapies---cohere closely with my husband and my experience of using such treatments for our son Charlie. In the three separate studies, the authors made an extensive review of published research about all three treatments; more than a few studies had to be discarded due to a lack of high-quality research.View full resource at care2.com

  • View Related
  • Share

Most Recently Shared on April 6, 2011 at 6:54 pm By:

PeterBrownPsy Peter H Brown Doctor and Psychologist

Some Benefits for Autistic Children From Medications & ABA, None From Secretin http://bit.ly/gHuWQh #autism

1 year ago...

Repligen Announces Completion Of Patient Treatment In Phase 3 Clinical Trial Of RG1068 In MRI Imaging Of The Pancreas

medicalnewstoday.com — “Repligen Corporation (Nasdaq: RGEN) reported that it has completed patient treatment in its Phase 3 clinical trial of RG1068, synthetic human secretin, in magnetic resonance imaging (MRI) of the pView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 20, 2009 at 11:46 am By:

mnt_clinical MNT Clinical Trials Health News

Repligen Announces Completion Of Patient Treatment In Phase 3 Clinical Trial Of RG1068 In MRI Imaging Of The Pa.. http://bit.ly/LmOze

3 years ago...

Repligen Announces FDA And EMA Approval Of Re-analysis Of Images From Phase 3 Trial Of RG1068 For Pancreatic Imaging

medicalnewstoday.com — “Repligen Corporation (Nasdaq: RGEN) announced that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company's proposal to re-analyze the images fromView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 29, 2010 at 1:06 pm By:

mnt_mri MNT MRI / Ultrasound Health News

Repligen Announces FDA And EMA Approval Of Re-analysis Of Images From Phase 3 Trial Of RG1068 For Pancreatic Imaging http://mnt.to/3Dh4

2 years ago...

Relate to Autism Resource Center

relatetoautism.com — “Relate to Autism Resource CenterView full resource at relatetoautism.com

  • View Related
  • Share

Most Recently Shared on April 5, 2011 at 6:20 pm By:

relate2autism Relate to Autism Support

"secretin as a treatment approach for ASDs warrants no further study" Pediatrics paper - abstract Resource Center http://bit.ly/secretin

1 year ago...

Autism medication, medication autism children, medication for autism

brighttots.com — “autism medication, medicaiton autism children, autism treatments, medication for autism, Information to medications used for treating autistic behaviors in children. Resources to autism and treatment.View full resource at brighttots.com

  • View Related
  • Share

Most Recently Shared on January 22, 2012 at 10:19 pm By:

Brighttots Bright Tots Health Site and Patient Advocate

Reports show that secretin reduces the severity of autism symptoms but, it's not approved by the FDA autism treatment. http://t.co/gHWVX4fZ

4 months ago...

Current autism treatments have shortcomings, reviews find - Related Stories - AAP SmartBrief

smartbrief.com — “Three study reviews, published in Pediatrics , indicate that treating autism with the enzyme secretin is not effective and that there's little proof that other medications such as antipsychotics help imp--View full resource at smartbrief.com

  • View Related
  • Share

Most Recently Shared on April 4, 2011 at 7:13 pm By:

yayayarndiva P. Mimi Poinsett MD Pediatrician, Physician, and Doctor

Current #autism treatments have shortcomings, reviews find http://sbne.ws/r/7ag5 nb 3 study reviews in Pediatrics Journal

1 year ago...

Repligen reports positive results from RG1068 Phase 3 study to improve MRI of the pancreas

news-medical.net — “Repligen Corporation reported today positive top-line results from a Phase 3 study to evaluate the safety and efficacy of RG1068, synthetic human secretin, to improve magnetic resonance imaging (MRI) of the pancreas in patients with pancreatic disease using endoscopy (ERCP) as a diagnostic reference.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 14, 2011 at 5:21 pm By:

NewsMedical News-Medical.Net Health News

Repligen reports positive results from RG1068 Phase 3 study to improve MRI of the pancreas: Repligen Corporation... http://bit.ly/ecWGVz

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390